A patent judgment against Boston Scientific Corp. has jumped to $501 million after a Texas federal judge tacked on an additional $69 million in interest. U.S. District Judge John Ward ruled Thursday to expand the damages award -- decided by a federal jury in Marshall, Texas -- to cover interest on royalties dating back to the medical device maker's 2004 U.S. launch of drug-coated heart stents.
February 19, 2008 at 12:00 AM
1 minute read
The original version of this story was published on National Law Journal
A patent judgment against Boston Scientific Corp. has jumped to $501 million after a judge tacked on an additional $69 million in interest.
U.S. District Judge John Ward ruled Thursday to expand the damages award — decided by a federal jury in Marshall, Texas — to cover interest on royalties dating to the medical device maker’s 2004 U.S. launch of drug-coated heart stents.
Presented by BigVoodoo
Law firms & in-house legal departments with a presence in the middle east celebrate outstanding achievement within the profession.
The premier educational and networking event for employee benefits brokers and agents.
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
A large and well-established Tampa company is seeking a contracts administrator to support the company's in-house attorney and manage a wide...
We are seeking an attorney to join our commercial finance practice in either our Stamford, Hartford or New Haven offices. Candidates should ...
We are seeking an attorney to join our corporate and transactional practice. Candidates should have a minimum of 8 years of general corporat...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
